CERN Cerner Corporation

Cerner Achieves 500th Patent With Voice-Assisted Technology

Cerner Achieves 500th Patent With Voice-Assisted Technology

Company Builds on Long History of Industry-Leading Innovation

KANSAS CITY, Mo., Dec. 02, 2019 (GLOBE NEWSWIRE) -- (Nasdaq: CERN), a global health care technology company, has achieved its 500th patent, a new innovative voice-assisted technology designed to make it easier for clinicians to document the details of a patient visit on a mobile device. This milestone builds on Cerner’s legacy of technological advancement and industry-leading patent portfolio, validating the company’s rich 40-year history of transformation at the intersection of health care and technology.

Documentation becomes easier, faster and hands free with voice-assisted technology, bringing clinicians out from behind the keyboard and instead engaging directly with patients about their health. Cerner’s 500th patent expands its work in leveraging voice inputs and natural language processing to reduce the clinician’s documentation burden. The technology captures the verbal interaction between a clinician and patient to document the medical visit. Information relevant to the patient’s care is identified, extracted and presented directly on the clinician’s mobile device. The shorthand clinical note created helps the clinician complete more comprehensive documentation at a later time.  

“Our development of emerging technologies like voice recognition will help arm clinicians with tools that empower them to more fully engage with their patients and deliver smarter care,” said Dr. Tanuj Gupta, vice president and physician executive, Cerner Intelligence. “We’re tapping into our renowned history and expertise in health care technology to set the pace of advancement in the industry. Through our agile iterative approach, we’re bringing new innovation to our clients faster than before with the goal of making care delivery easier for clinicians and simpler for patients.”

With its 500th issued patent, Cerner has signaled a competitive edge in supporting clients through the next era of health care digitization. The company’s strong commitment to R&D is proof of its dedication to bringing forth new technologies that improve clinician and patient experiences and revolutionize how care is delivered. Leveraging its legacy of innovation and disruption, Cerner continues to seek new ways to build on top of the platforms it created and develop new solutions to shape the future of health care.

Cerner’s patent program is constantly evolving to address health care’s macro trends and advance the way clients deliver care. The company is exploring additional patents that support the migration of data to the cloud, intelligence and analytics to improve clinician and patient experiences, and predictive analytics and AI to improve health outcomes.

About Cerner

Cerner’s health technologies connect people and information systems at more than 27,500 contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers integrated clinical and financial systems to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit , ,  or connect on , ,  or . Nasdaq: CERN. Smarter Care. Better Outcomes. Healthier You. 

Media Contacts:

Cerner

Austin Cozzolino, Public Relations, (816) 786-2154,  

EN
02/12/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cerner Corporation

CERNER sees an upgrade to Slightly Positive due to a better fundamenta...

The general evaluation of CERNER (US), a company active in the Software industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date December 14, 2021, the closing price was USD 77.26 and...

 PRESS RELEASE

Cerner Announces Increased Quarterly Dividend

Cerner Announces Increased Quarterly Dividend Dividend of $0.27 per issued and outstanding share reflects 23% increase KANSAS CITY, Mo., Dec. 10, 2021 (GLOBE NEWSWIRE) --  (NASDAQ: CERN), a global healthcare technology company, today announced that its board of directors declared a cash dividend to stockholders of $0.27 per issued and outstanding share, up 23 percent from the prior quarterly dividend of $0.22. The cash dividend will be payable January 11, 2022, to shareholders of record as of the close of business December 27, 2021. Cerner intends to pay regular quarterly cash dividend...

 PRESS RELEASE

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Offic...

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Officer Experienced Clinical Executive to Lead Patient and Caregiver Experiences KANSAS CITY, Mo., Nov. 16, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, today announced Nasim Afsar, MD, MBA, MHM, as the company’s first Chief Health Officer, effective January 2022. In this new role, Dr. Afsar will lead Cerner’s more than 1,000 healthcare professionals who provide insight and guidance to product development and improving the lives of patients and caregivers. She will also lead the quality...

 PRESS RELEASE

Cerner Reports Third Quarter 2021 Results

Cerner Reports Third Quarter 2021 Results Delivers Strong Results Across Key MetricsGAAP Operating Margin and Diluted EPS Lower; Adjusted Operating Margin and Adjusted Diluted EPS Both up Sharply vs. Year-Ago QuarterFull-Year Guidance Increased KANSAS CITY, Mo., Oct. 29, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: CERN) today announced results for the 2021 third quarter that ended September 30, 2021. The third quarter 2021 earnings release can be viewed as well as on the company’s website at . Cerner will host an earnings conference call to provide additional detail on the Company’s results a...

 PRESS RELEASE

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcome...

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcomes Combining decades of healthcare, life sciences and collaborative research to transform the way care is delivered KANSAS CITY, Mo., Oct. 26, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, announces the launch of a new operating unit, SM, that offers data-driven solutions and research services to help bring clarity to multi-dimensional data through real-world evidence and insights. The combined expertise of the Cerner and Kantar Health teams is expected to help accelerate discovery, ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch